17 May 2022
PCR Tricuspid Focus Group update: present and future of tricuspid regurgitation treatment
Anchorperson:
J. Hausleiter
Moderator:
V. Delgado
Summary
Follow the discussions based on the case of an 85-year-old male patient with HTN, mild secondary PAH, DCM, LVEF 45 %, and surgical bioAVR and MVR, presenting with progressive SOB and signs of right HF, severe secondary TR 4/5, and permanent AF, and note the indications of tricuspid transcatheter edge-to-edge repair, among others!
Learning Objectives
- To be updated about the activities and future plans of the PCR Tricuspid Focus Group
- To become more familiar with imaging for tricuspid regurgitation classification and patient selection for interventional treatment
- To participate in a step-by-step overview of a standard tricuspid transcatheter edge-to-edge repair (TEER) procedure
